EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myocardial Viability and Ischaemia in Chronic Total Occlusion

Zia Mehmood, Preethi Suresh, Rui Li, Hosamadin Assadi iD, Bahman Kasmai, Kurian Thampi, Clint Maart iD, Timothy Gilbert, Simon Eccleshall iD, Chris Sawh, Sunil Nair, Rob J van der Geest iD und 4 weitere

Medicina · 13.03.2026 · 62 (3) · 540

DOI: 10.3390/medicina62030540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, online erschienen am 13.03.2026. Verfasst von Zia Mehmood und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich NR4 7UY, UK. Hauptthemen laut MEDLINE: Coronary Occlusion, Myocardial Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust Clinical Research Career Development Fellowships.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Chronic total occlusion (CTO) affects 30% of patients undergoing coronary angiography rendering poorer outcomes. While percutaneous coronary intervention (PCI) can be technically successful, RCTs show no survival benefit. Cardiovascular Magnetic Resonance (CMR) provides comprehensive myocardial phenotyping, offering prognostic insights in this high-risk cohort. Materials and Methods: Fifty-six patients with angiographically confirmed CTO underwent stress perfusion CMR with late gadolinium enhancement. Myocardial function, ischaemia and scar burden were quantified and compared across CTO territory and viability subgroups.

Results

In patients with CTO, 27% of patients (15/56) had no viability. In patients with viable myocardium, 66% (27/41) demonstrated reversible ischaemia. Viable myocardium was associated with significantly higher LV stroke volumes (93.6 ± 20.1 mL vs. 80.9 ± 18.4 mL, p = 0.039), along with lower LV scar mass (18.7 ± 13.5g vs. 32.3 ± 12.8g; p = 0.002) and scar percentage (14.9 ± 8.3% vs. 25.9 ± 7.5%; p = 0.001). Viable myocardium showed more ischaemia both globally (11.6 ± 14.3g vs. 0.2 ± 9.3g; p = 0.005) and within the CTO territory (10.3 ± 10.3% vs. 2.3 ± 2.7%; p = 0.01). Non-viable myocardium was associated with significantly higher CTO-territory scar mass (9.4 ± 6.5 g vs. 5.1 ± 6.9 g; p = 0.046) and scar percentage (21.8 ± 13.3% vs. 11.7 ± 12.8%; p = 0.01), indicating extensive fibrosis. A scar burden threshold of 11.18% in CTO territory predicted non-viability with 80% sensitivity and 65.85% specificity (AUC = 0.701 [95% CI 0.54–0.87], p = 0.019).

Conclusions

Among CTO patients, 27% harbour no viability, while patients with viable myocardium typically exhibit reversible ischaemia—representing a phenotype with preserved viability and inducible ischaemia. These findings support the use of multiparametric CMR to phenotype CTO territories prior to considering CTO-PCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary OcclusionMyocardial IschemiaHumansMaleFemaleMiddle AgedAgedMyocardiumCoronary AngiographyChronic DiseaseMagnetic Resonance ImagingTissue Survival

Stichwörter der Autor:innen

cardiac magnetic resonance imagingchronic total occlusionlate gadolinium enhancementmyocardial ischaemiamyocardial viability

Autor:innen und Institutionen

  • Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich NR4 7UY, UK.
  • Department of Cardiovascular and Metabolic Health, Norwich Medical School, University of East Anglia, Norwich NR4 7UQ, UK.
  • Department of Radiology, Division of Image Processing, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.

ORCID-Profile: Hosamadin Assadi, Clint Maart, Simon Eccleshall, Rob J van der Geest, Vassilios S Vassiliou, Pankaj Garg

Förderung

  • Wellcome Trust Clinical Research Career Development Fellowships

Zitieren

APA

Mehmood, Z., Suresh, P., Li, R., Assadi, H., Kasmai, B., Thampi, K., Maart, C., Gilbert, T., Eccleshall, S., Sawh, C., Nair, S., van der Geest, R. J., Vassiliou, V. S., Ryding, A., Matthews, G., & Garg, P. (2026). Myocardial Viability and Ischaemia in Chronic Total Occlusion. Medicina, 62(3), 540. https://doi.org/10.3390/medicina62030540

Vancouver

Mehmood Z, Suresh P, Li R, Assadi H, Kasmai B, Thampi K, et al. Myocardial Viability and Ischaemia in Chronic Total Occlusion. Medicina. 2026;62(3):540. doi:10.3390/medicina62030540

BibTeX
@article{Mehmood2026,
  author = {Mehmood, Zia and Suresh, Preethi and Li, Rui and Assadi, Hosamadin and Kasmai, Bahman and Thampi, Kurian and Maart, Clint and Gilbert, Timothy and Eccleshall, Simon and Sawh, Chris and Nair, Sunil and van der Geest, Rob J and Vassiliou, Vassilios S and Ryding, Alisdair and Matthews, Gareth and Garg, Pankaj},
  title = {Myocardial Viability and Ischaemia in Chronic Total Occlusion},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {3},
  pages = {540},
  doi = {10.3390/medicina62030540}
}
Kostenlos starten →